These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35334309)

  • 1. Interactions between glucosides of the tip of the S1 subunit of SARS-CoV-2 spike protein and dry and wet surfaces of CuO and Cu-A model for the surfaces of coinage metals.
    Lousada CM
    Colloids Surf B Biointerfaces; 2022 Jun; 214():112465. PubMed ID: 35334309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer simulations of the interaction between SARS-CoV-2 spike glycoprotein and different surfaces.
    Malaspina DC; Faraudo J
    Biointerphases; 2020 Oct; 15(5):051008. PubMed ID: 33105999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer Simulation of the Interaction between SARS-CoV-2 Spike Protein and the Surface of Coinage Metals.
    Sahihi M; Faraudo J
    Langmuir; 2022 Dec; 38(48):14673-14685. PubMed ID: 36418228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Nanomechanical Study on Deciphering the Stickiness of SARS-CoV-2 on Inanimate Surfaces.
    Xie L; Liu F; Liu J; Zeng H
    ACS Appl Mater Interfaces; 2020 Dec; 12(52):58360-58368. PubMed ID: 33337873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
    Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
    J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein.
    Van Ert HA; Bohan DW; Rogers K; Fili M; Rojas Chávez RA; Qing E; Han C; Dempewolf S; Hu G; Schwery N; Sevcik K; Ruggio N; Boyt D; Pentella MA; Gallagher T; Jackson JB; Merrill AE; Knudson CM; Brown GD; Maury W; Haim H
    Microbiol Spectr; 2022 Feb; 10(1):e0267621. PubMed ID: 35080430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellulosic copper nanoparticles and a hydrogen peroxide-based disinfectant trigger rapid inactivation of pseudoviral particles expressing the Spike protein of SARS-CoV-2, SARS-CoV, and MERS-CoV.
    Brault A; Néré R; Prados J; Boudreault S; Bisaillon M; Marchand P; Couture P; Labbé S
    Metallomics; 2022 Jul; 14(7):. PubMed ID: 35731587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis.
    Rodal Canales FJ; Pérez-Campos Mayoral L; Hernández-Huerta MT; Sánchez Navarro LM; Matias-Cervantes CA; Martínez Cruz M; Cruz Parada E; Zenteno E; Ramos-Martínez EG; Pérez-Campos Mayoral E; Romero Díaz C; Pérez-Campos E
    Sci Rep; 2021 Nov; 11(1):22288. PubMed ID: 34782703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Aβ
    Hsu JT; Tien CF; Yu GY; Shen S; Lee YH; Hsu PC; Wang Y; Chao PK; Tsay HJ; Shie FS
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection.
    Letarov AV; Babenko VV; Kulikov EE
    Biochemistry (Mosc); 2021 Mar; 86(3):257-261. PubMed ID: 33838638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit.
    Asandei A; Mereuta L; Schiopu I; Park J; Seo CH; Park Y; Luchian T
    ACS Appl Mater Interfaces; 2020 Dec; 12(50):55649-55658. PubMed ID: 33270413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and Orientation of the SARS-Coronavirus-2 Spike Protein at Air-Water Interfaces.
    Bregnhøj M; Roeters SJ; Chatterley AS; Madzharova F; Mertig R; Pedersen JS; Weidner T
    J Phys Chem B; 2022 May; 126(18):3425-3430. PubMed ID: 35477296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.
    Kalathiya U; Padariya M; Fahraeus R; Chakraborti S; Hupp TR
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the competitive inhibitor efficacy of frog-skin alpha helical AMPs identified against ACE2 binding to SARS-CoV-2 S1 spike protein as therapeutic scaffold to prevent COVID-19.
    Sekar PC; Srinivasan E; Chandrasekhar G; Paul DM; Sanjay G; Surya S; Kumar NSAR; Rajasekaran R
    J Mol Model; 2022 Apr; 28(5):128. PubMed ID: 35461388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
    Behloul N; Baha S; Shi R; Meng J
    Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption of SARS-CoV-2 Spike Protein S1 at Oxide Surfaces Studied by High-Speed Atomic Force Microscopy.
    Xin Y; Grundmeier G; Keller A
    Adv Nanobiomed Res; 2021 Feb; 1(2):2000024. PubMed ID: 33615316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.